Don’t Roll the Dice with MDMA, Part 2
Even one of the researchers for MDMA-assisted therapy acknowledged several problems with the therapy.
09/26/23
Search Results for: "Don’t Roll the Dice with MDMA"
09/19/23
Don’t Roll the Dice with MDMA, Part 1
Should the FDA approve MDMA-assisted therapy? Should we roll the dice and see what happens? A recent survey noted Americans have mixed feelings.
04/16/24
Psychedelics as the Newest Psychiatric Craze, Part 2
On December 12, 2023 the MAPS Public Benefit Corporation announced it submitted a new drug application (NDA) to the FDA for MDMA-assisted therapy. MAPS PBC (now called Lykos Therapeutics) requested the FDA grant a priority review, given that MDMA received a Breakthrough Therapy designation in 2017. The FDA has 60 days to determine whether the […]